Abvc Biopharma (ABVC) Other Non-Current Assets (2009 - 2026)
Abvc Biopharma's Other Assets came in at $1.92 million for Q3 2026, down 0.5% from $1.93 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Other Assets was $1.93 million, down 0.8% from FY2024.
- Other Assets carries a five-year compound annual growth rate of 63.6% (FY2020 to FY2025).
- Going back by year, Other Assets was $1.95 million in FY2024 (-70.9%), $6.71 million in FY2023 (+347.1%), $1.5 million in FY2022 (+835.0%) and $160,466 in FY2021 (-2.6%).
- The five-year range for quarterly Other Assets is $150,076 (Q2 2022) to $6.71 million (Q4 2023).
- Year-over-year, Other Assets increased in five of the last eight quarters, with growth averaging 61.6%.
- The fastest year-over-year change in Other Assets over five years came in Q4 2022 (growth of 835.0%), and the weakest in Q4 2024 (a decline of 70.9%).
- Business Quant data shows ABVC's Other Assets at $1.92 million (Q2 2026), $2.59 million (Q1 2026) and $1.93 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 1.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.92 Mn |
| Jun 30, 2026 | 1.92 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 833,204.00 |
| Mar 31, 2025 | 819,028.00 |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 691,900.00 |
| Jun 30, 2024 | 691,900.00 |
| Mar 31, 2024 | 691,900.00 |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 408,946.00 |
| Mar 31, 2023 | 412,959.00 |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 160,874.00 |
| Jun 30, 2022 | 150,076.00 |
| Mar 31, 2022 | 156,397.00 |
| Dec 31, 2021 | 160,466.00 |
API Access
Abvc Biopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();